Germany In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

GlobalData, December 2012, Pages: 300

Germany In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

Our new report, “Germany In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Germany In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology Culture and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology Culture and Genetic Testing.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Germany In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Inc., Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Germany In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In Germany
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics Market, Germany, Revenue Mix ($m), 2011
3.4 In Vitro Diagnostics Market, Germany, Category Contribution (%), 2011
3.5 In Vitro Diagnostics, Germany, Company Share (2010-2011)
4 Clinical Chemistry In Germany
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, Germany, Revenue Mix ($m), 2011
4.3 Clinical Chemistry Market, Germany, Segment Contribution (%), 2011
4.4 Clinical Chemistry Overall Revenue, (2004-2018)
4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018)
4.4.2 Urine Analysis, Revenue (2004-2018)
4.5 Clinical Chemistry Distribution Share (2010-2011)
4.6 Clinical Chemistry, Germany, Company Share (2010-2011)
5 Genetic Testing In Germany
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, Germany, Revenue Mix ($m), 2011
5.3 Genetic Testing Market, Germany, Segment Contribution (%), 2011
5.4 Genetic Testing Overall Revenue, (2004-2018)
5.5 Genetic Testing Distribution Share (2010-2011)
5.6 Genetic Testing, Germany, Company Share (2010-2011)
6 Haematology In Germany
6.1 Haematology Market, Market Segmentation
6.2 Haematology Market, Germany, Revenue Mix ($m), 2011
6.3 Haematology Market, Germany, Segment Contribution (%), 2011
6.4 Haematology Overall Revenue, (2004-2018)
6.4.1 Haematology Reagents, Revenue (2004-2018)
6.4.2 Immunohaematology, Revenue (2004-2018)
6.4.3 Haemostasis, Revenue (2004-2018)
6.4.4 Haematology Rapid Tests, Revenue (2004-2018)
6.4.5 Haematology Cell Counters, Revenue (2004-2018)
6.5 Haematology Distribution Share (2010-2011)
6.6 Haematology, Germany, Company Share (2010-2011)
7 Histology And Cytology In Germany
7.1 Histology and Cytology Market, Market Segmentation
7.2 Histology And Cytology Market, Germany, Revenue Mix ($m), 2011
7.3 Histology And Cytology Market, Germany, Segment Contribution (%), 2011
7.4 Histology And Cytology Overall Revenue, (2004-2018)
7.5 Histology And Cytology Distribution Share (2010-2011)
7.6 Histology And Cytology, Germany, Company Share (2010-2011)
8 Immuno Chemistry In Germany
8.1 Immuno Chemistry Market, Germany, Revenue Mix ($m), 2011
8.2 Immuno Chemistry Market, Germany, Segment Contribution (%), 2011
8.3 Immuno Chemistry Overall Revenue, (2004-2018)
8.3.1 Disease Specific Immunochemistry, Revenue (2004-2018)
8.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018)
8.3.3 Endocrinology Tests, Revenue (2004-2018)
8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018)
8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018)
8.3.6 Immunochemistry Analyzers, Revenue (2004-2018)
8.4 Immuno Chemistry Distribution Share (2010-2011)
8.5 Immuno Chemistry, Germany, Company Share (2010-2011)
9 Infectious Immunology In Germany
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, Germany, Revenue Mix ($m), 2011
9.3 Infectious Immunology Market, Germany, Segment Contribution (%), 2011
9.4 Infectious Immunology Overall Revenue, (2004-2018)
9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018)
9.5 Infectious Immunology Distribution Share (2010-2011)
9.6 Infectious Immunology, Germany, Company Share (2010-2011)
10 Microbiology Culture In Germany
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, Germany, Revenue Mix ($m), 2011
10.3 Microbiology Culture Market, Germany, Segment Contribution (%), 2011
10.4 Microbiology Culture Overall Revenue, (2004-2018)
10.4.1 Microbiology Analyzers, Revenue (2004-2018)
10.5 Microbiology Culture Distribution Share (2010-2011)
10.6 Microbiology Culture, Germany, Company Share (2010-2011)
11 Overview of Key Companies in Germany In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Share in the Germany In Vitro Diagnostics Market
11.2 Siemens Healthcare
11.2.1 Company Overview
11.2.2 Share in the Germany In Vitro Diagnostics Market
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Share in the Germany In Vitro Diagnostics Market
11.4 Beckman Coulter, Inc.
11.4.1 Company Overview
11.4.2 Share in the Germany In Vitro Diagnostics Market
11.5 Ortho-Clinical Diagnostics Inc.
11.5.1 Company Overview
11.5.2 Share in the Germany In Vitro Diagnostics Market
11.6 bioMerieux S.A.
11.6.1 Company Overview
11.6.2 Share in the Germany In Vitro Diagnostics Market
11.7 Sysmex Corporation
11.7.1 Company Overview
11.8 Bio-Rad Laboratories, Inc.
11.8.1 Company Overview
11.9 Alere Inc.
11.9.1 Company Overview
11.10 Becton, Dickinson and Company
11.10.1 Company Overview
11.11 Phadia AB
11.11.1 Company Overview
11.12 Qiagen N.V.
11.12.1 Company Overview
11.13 Diagnostica Stago, Inc.
11.13.1 Company Overview
11.14 DiaSorin S.p.A
11.14.1 Company Overview
11.15 Horiba, Ltd.
11.15.1 Company Overview
11.16 Olympus Corporation
11.16.1 Company Overview
11.17 Gen-Probe Incorporated
11.17.1 Company Overview
11.18 PerkinElmer, Inc.
11.18.1 Company Overview
11.19 Mindray Medical International Limited
11.19.1 Company Overview
11.20 Thermo Fisher Scientific Inc.
11.20.1 Company Overview
11.21 Grifols, S.A.
11.21.1 Company Overview
11.22 Immucor, Inc.
11.22.1 Company Overview
11.23 Life Technologies Corporation
11.23.1 Company Overview
11.24 Horiba, Ltd.
11.24.1 Company Overview
12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology And Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products
13 Financial Deals Landscape
13.1 Acquisition
13.1.1 Ametek Completes Acquisition Of Dunkermotoren From Triton Advisers For $330 Million
13.1.2 Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For $2.6 Million
13.1.3 B. Braun Melsungen Acquires 20% Stake In CeGaT
13.1.4 Eppendorf Acquires Dasgip Group, Developer Of Bioreactor Systems
13.1.5 Roche To Acquire Verum Diagnostica For $17.4 Million
13.2 Partnerships
13.2.1 BioCat Enters Into Distribution Agreement With Alpco Diagnostics For ELISA Kits
13.2.2 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
13.2.3 Scienion Enters Into Co-Development Agreement With Genomica
13.2.4 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
13.2.5 Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology
13.2.6 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
13.2.7 BioDot Enters Into Co-Marketing Agreement With JOT Automation
13.2.8 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
13.2.9 Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx
13.2.10 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
13.2.11 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
13.2.12 Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing
13.2.13 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
13.2.14 Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero
13.2.15 Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
13.2.16 Genalyte Partners Scienion To Provide Sciflexarrayer Dispensers For Maverick Detection Platform
13.2.17 CML HealthCare Enters Into Agreement With MaRS Innovation
13.2.18 Akrivis Technologies Enters Into Co-Development Agreement With United States Biological
13.2.19 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
13.2.20 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
13.2.21 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
13.2.22 Curetis Enters Into Licensing Agreement With Cempra For Unyvero
13.2.23 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
13.2.24 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
13.2.25 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
13.2.26 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
13.2.27 Courtagen Life Sciences Enters Into Licensing Agreement With Scienion For sciFlexArrayer Technology
13.2.28 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
13.2.29 Leica Microsystems Enters Into Integration Agreement With Indica Labs
13.2.30 Epigenomics Enters Into Licensing Agreement With Companion Dx Reference Lab For Septin9 Biomaker
13.2.31 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
13.2.32 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
13.2.33 One Lambda Enters Into Co-Marketing Agreement With CellTrend
13.2.34 BioGenes Enters Into Co-Development Agreement With Boehringer Ingelheim
13.2.35 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
13.2.36 Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E
13.2.37 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
13.2.38 Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel
13.2.39 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
13.2.40 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
13.2.41 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
13.2.42 Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System
13.2.43 Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products
13.2.44 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
13.2.45 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
13.2.46 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
13.2.47 LipoScience Enters Into Licensing Agreement With Cleveland Clinic
13.2.48 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
13.2.49 NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
13.2.50 Bernhard Nocht Institute Enters Into Co-Development Agreement With altona DIAGNOSTICS
13.2.51 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
13.2.52 Accuray Enters Into Co-Development Agreement With University of Heidelberg
13.2.53 Protagen Enters Into Co-Development Agreement With University of Tuebingen
13.2.54 Apceth Enters Into Co-Development Agreement With Indivumed For Biomarker Platform
13.2.55 Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis
13.2.56 QIAGEN Enters Into Co-Development Agreement With Max Planck Institute
14 Recent Developments
14.1 Strategy And Business Planning
14.1.1 Sep 18, 2012: Hycor Opens European Center Of Operations In Germany To Support European Distributors And Customers
14.1.2 Sep 17, 2012: Boehringer Ingelheim To ShutDown One API Plant In Petersburg, Virginia
14.1.3 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs
14.1.4 Jun 18, 2012: Boehringer Ingelheim Sets Up Distinctive Brand For Biopharmaceutical Contract Manufacturing Business
14.1.5 May 31, 2012: Boehringer Ingelheim Expands Development Capacities With New Technical Center
14.1.6 Mar 12, 2012: SAW Instruments Expands Presence In US
14.1.7 Dec 19, 2011: Gerresheimer Extends Production Of Medical Plastic Systems In Bavaria
14.2 Research And Development
14.2.1 Sep 28, 2012: Octapharma Opens €25m Recombinant Research Facility In Heidelberg, Germany
14.2.2 Sep 19, 2012: Ten Pharmaceutical Companies Unite To Accelerate Development Of New Medicines
14.2.3 Apr 18, 2012: 4SC Discovery And Crelux Enter Into Strategic Alliance For Joint Drug Discovery Services
14.2.4 Jan 09, 2012: Bayer HealthCare To Share Lab Space With Start-Up Companies
14.3 Product News
14.3.1 Sep 27, 2012: Bruker Announces European Launch Of Toxtyper Clinical Mass Spectrometry Screening Solution For Toxicology At DGKL Annual Conference
14.3.2 Sep 25, 2012: Aeterna Zentaris Receives European Patent For AEZS-130 In Growth Hormone Deficiency Diagnosis
14.3.3 Aug 20, 2012: LifeCodexx Launches PraenaTest In Germany, Austria, Liechtenstein And Switzerland With Sequenom-Licensed Technology
14.3.4 Aug 14, 2012: SIRS-Lab Completes Enrollment In Clinical Trial To Evaluate Pathogen Detection Test VYOO For Patients With Suspected Sepsis
14.3.5 Aug 13, 2012: Roche Launches New CE Certified MagNA Pure 96 System For Reliable Nucleic Acid Extraction
14.3.6 Jul 18, 2012: Curetis Signs Distribution Agreement With ATC For Unyvero Solution In Middle East
14.3.7 Apr 27, 2012: LifeCodexx Successfully Completes Clinical Validation Of Noninvasive Prenatal Test Method Of Trisomy 21
14.3.8 Apr 17, 2012: QIAGEN Receives FDA Clearance For artus Infl A/B RG RT-PCR Kit
14.3.9 Apr 04, 2012: XDx Launches AlloMap Molecular Expression Test In Germany
14.3.10 Mar 30, 2012: Abbott's PLEX-ID Molecular System And Tests For Broad Microbial Identification Obtain CE Marking
14.3.11 Jan 20, 2012: Signature Diagnostics To Present Detector C 2.0 Blood Test For Early Detection Of Colorectal Cancer At ASCO 2012 Gastrointestinal Cancer Symposium In San Francisco
14.3.12 Jan 10, 2012: GATC Biotech And LifeCodexx Complete Recruitment Of Blood Samples For Clinical Study Of LifeCodexx PraenaTest
14.3.13 Dec 07, 2011: WILEX Lists Oncogene Science CA IX IHC Kit As An In-Vitro-Diagnostic With FDA
15 Appendix
15.1 Definitions of Markets Covered in the Report
15.1.1 In Vitro Diagnostics
15.2 Research Methodology
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panels
15.8 Consulting
15.9 Currency Conversion
15.10 Contact Us
15.11 Disclaimer

1.1 List of Tables
Table 1: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: In Vitro Diagnostics Market, Germany, Category Contribution (%), 2011
Table 3: In Vitro Diagnostics Market, Germany, Cross-Category Analysis, 2004-2018
Table 4: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: In Vitro Diagnostics, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 7: Clinical Chemistry Market, Germany, Segment Contribution (%), 2011
Table 8: Clinical Chemistry, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 9: Clinical Chemistry, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 10: Clinical Chemisty Analyzers, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 11: Clinical Chemisty Analyzers, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 12: Urine Analysis, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 13: Urine Analysis, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 14: Clinical Chemistry, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Clinical Chemistry, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Genetic Testing Market, Germany, Segment Contribution (%), 2011
Table 17: Genetic Testing, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Genetic Testing, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Genetic Testing, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Genetic Testing, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Haematology Market, Germany, Segment Contribution (%), 2011
Table 22: Haematology, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 23: Haematology, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 24: Haematology Reagents, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 25: Haematology Reagents, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 26: Immunohaematology, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 27: Immunohaematology, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 28: Haemostasis, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 29: Haemostasis, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 30: Haematology Rapid Tests, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 31: Haematology Rapid Tests, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 32: Haematology Cell Counters, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 33: Haematology Cell Counters, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 34: Haematology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: Haematology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Histology And Cytology Market, Germany, Segment Contribution (%), 2011
Table 37: Histology And Cytology, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 38: Histology And Cytology, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 39: Histology And Cytology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 40: Histology And Cytology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Immuno Chemistry Market, Germany, Segment Contribution (%), 2011
Table 42: Immuno Chemistry, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 43: Immuno Chemistry, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 44: Disease Specific Immunochemistry, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 45: Disease Specific Immunochemistry, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 46: Drugs of Abuse / Toxicology, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 47: Drugs of Abuse / Toxicology, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 48: Endocrinology Tests, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 49: Endocrinology Tests, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 50: Immunochemistry Rapid Tests, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 51: Immunochemistry Rapid Tests, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 52: Therapeutic Drug Monitoring, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 53: Therapeutic Drug Monitoring, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 54: Immunochemistry Analyzers, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 55: Immunochemistry Analyzers, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 56: Immuno Chemistry, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Immuno Chemistry, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 58: Infectious Immunology Market, Germany, Segment Contribution (%), 2011
Table 59: Infectious Immunology, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 60: Infectious Immunology, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 61: Infectious Immunology Rapid Tests, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 62: Infectious Immunology Rapid Tests, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 63: Infectious Immunology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 64: Infectious Immunology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 65: Microbiology Culture Market, Germany, Segment Contribution (%), 2011
Table 66: Microbiology Culture, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 67: Microbiology Culture, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 68: Microbiology Analyzers, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 69: Microbiology Analyzers, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 70: Microbiology Culture, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 71: Microbiology Culture, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 72: Clinical Chemisty Market Pipeline Products
Table 73: Immuno Chemistry Market Pipeline Products
Table 74: Haematology Market Pipeline Products
Table 75: Infectious Immunology Market Pipeline Products
Table 76: Microbiology Culture Market Pipeline Products
Table 77: Histology And Cytology Market Pipeline Products
Table 78: Genetic Testing Market Pipeline Products
Table 79: Ametek Completes Acquisition Of Dunkermotoren From Triton Advisers For $330 Million
Table 80: Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For $2.6 Million
Table 81: B. Braun Melsungen Acquires 20% Stake In CeGaT
Table 82: Eppendorf Acquires Dasgip Group, Developer Of Bioreactor Systems
Table 83: Roche To Acquire Verum Diagnostica For $17.4 Million
Table 84: BioCat Enters Into Distribution Agreement With Alpco Diagnostics For ELISA Kits
Table 85: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
Table 86: Scienion Enters Into Co-Development Agreement With Genomica
Table 87: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
Table 88: Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology
Table 89: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
Table 90: BioDot Enters Into Co-Marketing Agreement With JOT Automation
Table 91: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
Table 92: Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx
Table 93: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
Table 94: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Table 95: Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing
Table 96: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
Table 97: Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero
Table 98: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
Table 99: Genalyte Partners Scienion To Provide Sciflexarrayer Dispensers For Maverick Detection Platform
Table 100: CML HealthCare Enters Into Agreement With MaRS Innovation
Table 101: Akrivis Technologies Enters Into Co-Development Agreement With United States Biological
Table 102: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
Table 103: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
Table 104: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
Table 105: Curetis Enters Into Licensing Agreement With Cempra For Unyvero
Table 106: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
Table 107: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Table 108: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
Table 109: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Table 110: Courtagen Life Sciences Enters Into Licensing Agreement With Scienion For sciFlexArrayer Technology
Table 111: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
Table 112: Leica Microsystems Enters Into Integration Agreement With Indica Labs
Table 113: Epigenomics Enters Into Licensing Agreement With Companion Dx Reference Lab For Septin9 Biomaker
Table 114: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
Table 115: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
Table 116: One Lambda Enters Into Co-Marketing Agreement With CellTrend
Table 117: BioGenes Enters Into Co-Development Agreement With Boehringer Ingelheim
Table 118: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Table 119: Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E
Table 120: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Table 121: Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel
Table 122: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Table 123: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Table 124: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Table 125: Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System
Table 126: Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products
Table 127: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
Table 128: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
Table 129: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
Table 130: LipoScience Enters Into Licensing Agreement With Cleveland Clinic
Table 131: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
Table 132: NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
Table 133: Bernhard Nocht Institute Enters Into Co-Development Agreement With altona DIAGNOSTICS
Table 134: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
Table 135: Accuray Enters Into Co-Development Agreement With University of Heidelberg
Table 136: Protagen Enters Into Co-Development Agreement With University of Tuebingen
Table 137: Apceth Enters Into Co-Development Agreement With Indivumed For Biomarker Platform
Table 138: Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis
Table 139: QIAGEN Enters Into Co-Development Agreement With Max Planck Institute

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: In Vitro Diagnostics Market, Germany, Revenue Mix ($m), 2011
Figure 4: In Vitro Diagnostics Market, Germany, Category Contribution (%), 2011
Figure 5: In Vitro Diagnostics Market, Germany, Cross-Category Analysis, 2004-2018
Figure 6: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: In Vitro Diagnostics, Germany, Company Share (%), 2011
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, Germany, Revenue Mix ($m), 2011
Figure 11: Clinical Chemistry Market, Germany, Segment Contribution (%), 2011
Figure 12: Clinical Chemistry, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: Clinical Chemistry, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: Clinical Chemisty Analyzers, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 15: Clinical Chemisty Analyzers, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 16: Urine Analysis, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 17: Urine Analysis, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 18: Clinical Chemistry, Germany, Company Share (%), 2011
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, Germany, Revenue Mix ($m), 2011
Figure 21: Genetic Testing Market, Germany, Segment Contribution (%), 2011
Figure 22: Genetic Testing, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 23: Genetic Testing, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 24: Genetic Testing, Germany, Company Share (%), 2011
Figure 25: Haematology Market, Market Segmentation
Figure 26: Haematology Market, Germany, Revenue Mix ($m), 2011
Figure 27: Haematology Market, Germany, Segment Contribution (%), 2011
Figure 28: Haematology, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 29: Haematology, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 30: Haematology Reagents, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 31: Haematology Reagents, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 32: Immunohaematology, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
bioMerieux S.A.
Sysmex Corporation
Bio-Rad Laboratories, Inc.
Alere Inc.
Becton, Dickinson and Company
Phadia AB
Qiagen N.V.
Diagnostica Stago, Inc.
DiaSorin S.p.A
Horiba, Ltd.
Olympus Corporation
Gen-Probe Incorporated
PerkinElmer, Inc.
Mindray Medical International Limited
Thermo Fisher Scientific Inc.
Grifols, S.A.
Immucor, Inc.
Life Technologies Corporation
Horiba, Ltd.

Customers who bought this item also bought

• Germany In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
• Germany Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
• Germany Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• Germany Electronic Cigarettes Market 2011-2015
• Nephrology and Urology Devices Market Outlook in Germany to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others
• Drug Delivery Devices Market Outlook in Germany to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
• Future Horizons in the German Immunodiagnostics Market: Supplier Shares and Sales Forecasts for 100 Chemistry, TDM, Endocrine, Cancer, Immunoprotein and Abused Drug Tests by Market Segment
• ENT Devices Market Outlook in Germany to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
• German Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
• Neurology Devices Market Outlook in Germany to 2017 - Neurostimulation Devices, Interventional Neurology and Others